Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation

Mark Lee, Jin Ho Jang, Hyo Jin Min, PhD, Hyung In Jang, Jung Hwa Nah, Chuhl Joo Lyu, MD PhD, Kyou Sup Han, MD PhD, Jong-Ho Won, MD, Young Ho Lee, MD PhD, So Young Chong, MD, Yeung Chul Mun, MD PhD, Won Sik Lee, MD PhD, Seok Jin Kim, Inho Kim, MD PhD

Blood (2016) 128 (22): 3375.

https://doi.org/10.1182/blood.V128.22.3375.3375

Published: 2016

Journal Articles

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Kyoung Ha Kim, Lee Jae Hoon, Mark Lee, Kim Hoon-Gu, Young Rok Do, Yong Park, MD PhD, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Won Seog Kim, Sung-Kyu Park, MD, Jong-Ho Won, Jee Hyun Kong, Moo-Rim Park, MD, Je-Jung Lee, Jae-Yong Kwak, Hye Jin Kang, MD PhD, Yeung-Chul Mun

Blood (2016) 128 (22): 3466.

https://doi.org/10.1182/blood.V128.22.3466.3466

Published: 2016

Journal Articles

A Phase I Study of Idarubicin Dose Escalation for Remission Induction Therapy in Acute Myeloid Leukemia

Mark Lee, MD PhD, Sung-Yong Kim, MD

Blood (2015) 126 (23): 1344.

https://doi.org/10.1182/blood.V126.23.1344.1344

Published: 2015

Journal Articles

Final Report on Phase II Trial of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (Methotrexate, Ifosfamide, Etoposide, Dexamethasone, and L-asparaginase) Chemotherapy for Patients with Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Dok Hyun Yoon, MD PhD, Seok Jin Kim, MD PhD, Seong Hyun Jeong, MD, Dong-Yeop Shin, MD, Sung Hwa Bae, MD, Junshik Hong, MD, Seong Kyu Park, MD, Ho-Young Yhim, MD, Deok-Hwan Yang, MD, Hye Won Lee, MD, Mark Lee, MD PhD, Hyeonseok Eom, MD, PhD, Jae-Yong Kwak, MD PhD, Jae Hoon Lee, Cheolwon Suh, Won Seog Kim, MD PhD

Blood (2015) 126 (23): 3942.

https://doi.org/10.1182/blood.V126.23.3942.3942

Published: 2015

Journal Articles

What Can We Do for the Unrelated Donors of Hematopoietic Stem Cell to Lessen Their Agony?

Mark Lee, MD PhD, Jung Hwa Na, R.N., Hyung In Jang, R.N., Jin Ho Jang, R.N., Jongchan Lee, PhD, Chuhl Joo Lyu, MD PhD, Sung-Yong Kim, MD

Blood (2014) 124 (21): 5832.

https://doi.org/10.1182/blood.V124.21.5832.5832

Published: 2014

Journal Articles

Phase II Trial Of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (methotrexate, ifosfamide, etoposide, dexamethasone, and L-asparaginase) Chemotherapy For Patients With Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Seok Jin Kim, MD, PhD, Dok Hyun Yoon, MD, Seong Hyun Jeong, Dong-Yeop Shin, MD, Sung Hwa Bae, Junshik Hong, MD, Eun Kyung Park, Se Hyung Kim, Ho-Young Yhim, MD, Deok-Hwan Yang, MD, Hye Won Lee, Je-Jung Lee, MD, PhD, Mark Lee, MD, PhD, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, MD, PhD, Jae Hoon Lee, Dae Sik Hong, Cheolwon Suh, Won Seog Kim

Blood (2013) 122 (21): 3037.

https://doi.org/10.1182/blood.V122.21.3037.3037

Published: 2013

Journal Articles

Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation

Blood (2013) 122 (21): 5379.

https://doi.org/10.1182/blood.V122.21.5379.5379

Published: 2013

Journal Articles

Cutoff Value of Serum Ferritin Requiring Gastrointestinal Endoscopic Evaluation for Anemia

Mark Lee, MD, PhD, Eugene Park, M.D., Jongchan Lee, Ph.D., So-Young Kim, M.D., Sung-Yong Kim, M.D., Ph.D., Sun-Young Lee, M.D., Ph.D., Yo Han Cho, M.D., Ph.D., so Young Yoon, M.D., Ph.D.

Blood (2011) 118 (21): 5282.

https://doi.org/10.1182/blood.V118.21.5282.5282

Published: 2011

Journal Articles

Acute Myeloid Leukemia with Myelodysplasia-Related Changes (MRC) Did Not Show Inferior Outcomes Compared to Those without MRC,

Jee Hyun Kong, Hyun Ae Jung, Hee Kyung Ahn, Silvia Park, Hee-Jin Kim, MD, PhD, Kihyun Kim, MD, Jun Ho Jang, MD, PhD, Seok Jin Kim, MD, PhD, Won Seog Kim, Mark Lee, MD., PhD., Chul Jung

Blood (2011) 118 (21): 3563.

https://doi.org/10.1182/blood.V118.21.3563.3563

Published: 2011

Journal Articles

Serum Pro-Hepcidin Level in Helicobacter Pylori-Infected Iron Deficiency Anemia Patients.

Mark Lee, MD, PhD, Eun Young Song, Yeo Min Yun, So Young Yoon, Yo Han Cho, Sun-Young Lee, Sung-Yong Kim

Blood (2009) 114 (22): 5101.

https://doi.org/10.1182/blood.V114.22.5101.5101

Published: 2009

Journal Articles

Role of Homing Regulation in Coculturing Human Cord blood–derived Mesenchymal Stem cells with CD34-Positive Cells from Umbilical Cord Blood

Mark Lee, MD, PhD, Heesun Hong, Sung Yong Kim, Yo Han Cho, So Young Yoon

Blood (2008) 112 (11): 4747.

https://doi.org/10.1182/blood.V112.11.4747.4747

Published: 2008

Journal Articles

A Pilot Trial To Assess College Student’s Willingness To Donate Blood.

Derrick G. Demmons, MPH, Colleen P. Crittenden, DrPH, MPH, Mark Lee, PhD, Beth H. Shaz, MD, Miriam Burnett, MD, MDiv, MPH, Christopher D. Hillyer, MD

Blood (2007) 110 (11): 4029.

https://doi.org/10.1182/blood.V110.11.4029.4029

Published: 2007

Journal Articles

The Equal Activity of Azacytidine in 4 Risk Groups of IPSS in MDS.

Blood (2007) 110 (11): 4615.

https://doi.org/10.1182/blood.V110.11.4615.4615

Published: 2007

NARROW

Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

A Phase I Study of Idarubicin Dose Escalation for Remission Induction Therapy in Acute Myeloid Leukemia

Final Report on Phase II Trial of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (Methotrexate, Ifosfamide, Etoposide, Dexamethasone, and L-asparaginase) Chemotherapy for Patients with Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

What Can We Do for the Unrelated Donors of Hematopoietic Stem Cell to Lessen Their Agony?

Phase II Trial Of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (methotrexate, ifosfamide, etoposide, dexamethasone, and L-asparaginase) Chemotherapy For Patients With Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation

Cutoff Value of Serum Ferritin Requiring Gastrointestinal Endoscopic Evaluation for Anemia

Acute Myeloid Leukemia with Myelodysplasia-Related Changes (MRC) Did Not Show Inferior Outcomes Compared to Those without MRC,

Serum Pro-Hepcidin Level in Helicobacter Pylori-Infected Iron Deficiency Anemia Patients.

Role of Homing Regulation in Coculturing Human Cord blood–derived Mesenchymal Stem cells with CD34-Positive Cells from Umbilical Cord Blood

A Pilot Trial To Assess College Student’s Willingness To Donate Blood.

The Equal Activity of Azacytidine in 4 Risk Groups of IPSS in MDS.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only